ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620109 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620109; 2) Community: the network communities that were significantly associated with the response to NSC 620109; 3) Molecule: the relationships between components within communities and NSC 620109; 4) MDR: the compounds that were significantly associated with the NSC 620109.

NSC Compound Enrichment Correlation
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.00486817664672777 0.71159595
NSC 639512 Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00486817664672777 0.70019481
NSC 645159 Null 0.00486817664672777 0.65588569
NSC 645984 bis(2-Nitrophenyl)sulfilimine 0.00486817664672777 0.7310685
NSC 669158 1-Azido-2-formyl-benzo[ij]quinolizin-3-one 0.00486817664672777 0.78455709
NSC 671167 Null 0.00486817664672777 0.29639589
NSC 677697 7H-Pyrrolo[2,3-d]pyrimidine, 5,6-dimethyl- 2,4-bis(methylsulfinyl)-7-phenyl- 0.00486817664672777 0.7218302
NSC 711611 Null 0.00486817664672777 0.48780264
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00486817664672777 0.45925765
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00486817664672777 0.46742451
Total:113  Current:21    [First] [Prev] [Next] [Last]